Black Diamond Therapeutics, Inc. (BDTX)
Biological Products, (No Diagnostic Substances)
Latest Price
$2.03
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
1.68
P/B Ratio
1.21
Valuation metrics
adjust assumptions →EPS: $0.39
Book value / share: $1.96
Formula: √(22.5 × EPS × BVPS)
Graham Number
$4.15
+104% upside
EPS: $0.39
Target P/E: 15×
Formula: EPS × P/E
P/E Fair Value
$5.85
+188% upside
Institutional Ownership
57.7% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 4.45M | $8.0M | 7.74% | -- | 2026-06-30 |
| T. Rowe Price Investment Management, Inc. | 4.03M | $7.0M | 7.01% | -6.53M | 2026-06-30 |
| BlackRock, Inc. | 3.92M | $7.0M | 6.82% | +2.81M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.13M | $3.0M | 3.70% | -- | 2026-06-30 |
| RENAISSANCE TECHNOLOGIES LLC | 1.96M | $3.0M | 3.42% | +318.6K | 2026-06-30 |
| Defilade Capital Management, L.P. | 1.67M | $3.0M | 2.92% | -- | 2026-06-30 |
| DIMENSIONAL FUND ADVISORS LP | 1.37M | $2.0M | 2.38% | +63.7K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.22M | $2.0M | 2.12% | +681.6K | 2026-06-30 |
| Connor, Clark & Lunn Investment Management Ltd. | 1.09M | $2.0M | 1.90% | +34.5K | 2026-06-30 |
| AWM Investment Company, Inc. | 1.00M | $1.0M | 1.74% | +475.0K | 2026-06-30 |